Gregory Norden, Director of Praxis Precision Medicines PRAX, has filed 1 purchase and 2 sales on the open market. Over the past 12 months that comes to a net sale of $161.4K. The latest trade was on 06/10.

GN

GN

Gregory Norden

Director

Company

Praxis Precision Medicines PRAX

First filing

23/02/14

Trades

49 trades

Buys / sales

1 / 2

12-month net buying

−$161.4K

Last trade

06/10

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Royalty PharmaRPRX	Open-market sale10b5-1 plan	05/14	05/15	3,045 sh	$53.00	$161,385	−1.6%
Royalty PharmaRPRX	Open-market sale	25/08/11	25/08/11	33,500 sh	$36.23	$1,213,705	−14.7%
NT NanoString Technologies	Open-market buy	23/03/07	23/03/08	12,500 sh	$9.84	$123,000	+110.6%